Chemical industry – Page 24
-
OpinionWhy AlphaFold won’t revolutionise drug discovery
Protein structure prediction is a hard problem, but even harder ones remain
-
BusinessUK Reach costs stretch higher for industry
Government assessment suggests deadlines will be delayed and companies will pay billions for compliance data
-
NewsSoftware from Cambridge crystallographic experts could save pharma industry millions
Informatic tools will help drug formulators understand particle behaviour in their final product
-
OpinionMay cause side effects
The dose makes the poison, but understanding unwanted drug interactions is complicated
-
NewsUS chemical industry responsible for 25% of the country’s GDP
National Academies finds chemical research has ‘outsized economic value’
-
BusinessChemours sues over US PFAS safety limit
Fluoropolymer maker appeals new safety standard for GenX, calling it ‘scientifically unsound’
-
BusinessGas shortage puts pressure on chemical feedstocks
Demand for fuels has constricted European supplies, pushing up prices and threatening rationing
-
BusinessHaleon emerges from GSK consumer healthcare spin-off
Split illustrates move towards narrower focus in pharmaceuticals
-
ArticleMaking quality the priority for fine and specialty chemicals suppliers
Precision measurements and data integrity are essential in pharma and cosmetics supply chains
-
BusinessCalifornia advances plans to make its own insulin
Governor commits $100 million to develop low-cost insulin and build manufacturing facility to strengthen drug’s supply chain
-
BusinessSecond Theranos executive convicted of fraud
Blood testing startup president Ramesh ‘Sunny’ Balwani defrauded both investors and patients
-
BusinessNovartis cutting up to 8000 jobs
Restructure splits commercial activities geographically instead of by treatment area
-
BusinessUS reinstates Superfund taxes to clean up 1300 contaminated sites
Levy on 42 chemicals and their derivatives aims to revive neglected cleanup programme
-
OpinionAlzheimer’s, amyloid and abandoned antibodies
Biogen’s aducanumab is stumbling into obscurity. Where does that leave the amyloid hypothesis?
-
BusinessAt least 13 dead in massive chlorine release in Jordan
Tanker of gas fell during loading at the port of Aqaba, injuring hundreds
-
BusinessMeasuring biomolecules’ mass with light
Refeyn’s mass photometry is a new addition to the bioanalytical toolkit
-
BusinessDeadly explosion and fire at petrochemical plant in China
Transport vehicle driver killed and another employee injured at Sinopec in Shanghai
-
BusinessSoapbark branches out to fill essential role in vaccine recipes
The soapbark tree has long been used in traditional medicines, but is now coveted for some of our newest vaccines
-
FeatureUsing genetics to personalise prescriptions
We’ve known for a long time that different people respond to certain drugs to very different extents, but now cheap DNA testing could make these disparities a thing of the past, as Ian Le Guillou reports
-
BusinessDSM and Firmenich to merge
Flavour and fragrance-focused Firmenich complements DSM’s transition away from traditional chemicals